SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 278 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,608,000 | -12.0% | 21,350 | +77.6% | 0.08% | -14.3% |
| Q2 2019 | $1,827,000 | +36.2% | 12,021 | +6.8% | 0.10% | +44.1% |
| Q1 2019 | $1,341,000 | +56.5% | 11,255 | +43.4% | 0.07% | +36.0% |
| Q4 2018 | $857,000 | -44.5% | 7,850 | -17.8% | 0.05% | -25.4% |
| Q3 2018 | $1,543,000 | +25.1% | 9,555 | +2.4% | 0.07% | +116.1% |
| Q2 2018 | $1,233,000 | -37.2% | 9,329 | -64.8% | 0.03% | -38.0% |
| Q1 2018 | $1,962,000 | – | 26,478 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |